Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
Thomas Jefferson University · Johns Hopkins University · +8 more institutions
Abstract
Candidemia remains a major cause of morbidity and mortality in the health care setting, and the epidemiology of Candida infection is changing.
Clinical data from patients with candidemia were extracted from the Prospective Antifungal Therapy (PATH) Alliance database, a comprehensive registry that collects information regarding invasive fungal infections. A total of 2019 patients, enrolled from 1 July 2004 through 5 March 2008, were identified. Data regarding the candidemia episode were analyzed, including the specific fungal species and patient survival at 12 weeks after diagnosis.
Citation impact
- FWCI
- 36.85
- Percentile
- 100%
- References
- 50
Authors
10- DLDavid L. HornCorresponding
Thomas Jefferson University
- DNDionysios Neofytos
Johns Hopkins University, Thomas Jefferson University Hospital, Johns Hopkins Medicine
- EAElias Anaissie
University of Arkansas for Medical Sciences
- JAJay A. Fishman
Massachusetts General Hospital
- WJWilliam J. Steinbach
Duke University, Duke Medical Center
Topics & keywords
- Medicine
- Fluconazole
- Internal medicine
- Candida krusei
- Candida parapsilosis
- Epidemiology
- Incidence (geometry)
- Mortality rate
- Good health and well-being
Funding
- MGMassachusetts General Hospital
- UOUniversity of Miami
- UOUniversity of Pennsylvania
- EUEmory University
- BFBunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago
- UOUniversity of Minnesota
- UOUniversity of Washington
- JHJohns Hopkins University
- UOUniversity of Pittsburgh
- TJThomas Jefferson University
- COCity of Hope